Carisma Therapeutics Statistics

Total Valuation

CARM has a market cap or net worth of $42.79 million. The enterprise value is $7.96 million.

Market Cap	42.79M
Enterprise Value	7.96M

Important Dates

The last earnings date was Thursday, November 7, 2024, before market open.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

CARM has 41.54 million shares outstanding. The number of shares has increased by 183.73% in one year.

Current Share Class	41.54M
Shares Outstanding	41.54M
Shares Change (YoY)	+183.73%
Shares Change (QoQ)	+1.48%
Owned by Insiders (%)	12.30%
Owned by Institutions (%)	15.60%
Float	22.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.19
Forward PS	2.46
PB Ratio	128.10
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.38
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.25, with a Debt / Equity ratio of 10.44.

Current Ratio	3.25
Quick Ratio	2.81
Debt / Equity	10.44
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -216.21% and return on invested capital (ROIC) is -124.87%.

Return on Equity (ROE)	-216.21%
Return on Assets (ROA)	-49.37%
Return on Capital (ROIC)	-124.87%
Revenue Per Employee	$193,551
Profits Per Employee	-$677,579
Employee Count	107
Asset Turnover	0.22
Inventory Turnover	n/a

Taxes

Income Tax	-197,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -66.55% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-66.55%
50-Day Moving Average	0.99
200-Day Moving Average	1.48
Relative Strength Index (RSI)	54.72
Average Volume (20 Days)	130,830

Short Selling Information

The latest short interest is 1.05 million, so 2.52% of the outstanding shares have been sold short.

Short Interest	1.05M
Short Previous Month	1.10M
Short % of Shares Out	2.52%
Short % of Float	4.65%
Short Ratio (days to cover)	10.74

Income Statement

In the last 12 months, CARM had revenue of $20.71 million and -$72.50 million in losses. Loss per share was -$1.77.

Revenue	20.71M
Gross Profit	-51.03M
Operating Income	-75.97M
Pretax Income	-72.70M
Net Income	-72.50M
EBITDA	-72.61M
EBIT	-75.97M
Loss Per Share	-$1.77

Full Income Statement

Balance Sheet

The company has $41.91 million in cash and $3.76 million in debt, giving a net cash position of $38.15 million or $0.92 per share.

Cash & Cash Equivalents	41.91M
Total Debt	3.76M
Net Cash	38.15M
Net Cash Per Share	$0.92
Equity (Book Value)	360,000
Book Value Per Share	0.01
Working Capital	35.10M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$75.64 million and capital expenditures -$873,000, giving a free cash flow of -$76.51 million.

Operating Cash Flow	-75.64M
Capital Expenditures	-873,000
Free Cash Flow	-76.51M
FCF Per Share	-$1.84

Full Cash Flow Statement

Margins

Gross Margin	-246.38%
Operating Margin	-366.85%
Pretax Margin	-351.03%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-369.45%

Dividends & Yields

CARM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-183.73%
Shareholder Yield	-183.73%
Earnings Yield	-163.10%
FCF Yield	-172.12%

Dividend Details

Analyst Forecast

The average price target for CARM is $12.67, which is 1,130.10% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.67
Price Target Difference	1,130.10%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	-3.56%
EPS Growth Forecast (5Y)	-5.55%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CARM has an Altman Z-Score of -8.3 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.3
Piotroski F-Score	2